Antibe Therapeutics Reports Q2 2022 Interim Financial and Operating Results

Stock Information for Antibe Therapeutics

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Antibe Therapeutics

Antibe Announces Appointment of Receiver
Antibe Provides Update on CCAA Proceedings
Antibe Announces TSX Delisting Review
Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act
Canadian Investment Regulatory Organization Trade Resumption - ATE
Canadian Investment Regulatory Organization Trading Halt - ATE
Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act
Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.